PTGX Competitors & Alternatives
Compare Protagonist Therapeutics Inc with similar stocks in the same industry
Biotechnology
PTGX
Main Stock$119.00
Tradestie Score
63
Market Cap
$3.98B
Revenue Growth
1.0%
Analyst Upside
-0.3%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$170.49
|
$8.57B | - | 58 | Compare |
|
CAI
Caris Life Sciences, Inc. Common Stock
|
$17.50
|
$8.53B | - | 60 | Compare |
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$227.73
|
$8.30B | 2042.4 | 61 | Compare |
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 55 | Compare |
|
CYTK
Cytokinetics Inc.
|
$79.65
|
$6.68B | - | 61 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$105.00
|
$6.64B | - | 65 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$99.70
|
$6.38B | - | 50 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$29.76
|
$6.03B | - | 52 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$54.37
|
$6.02B | - | 58 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.44
|
$5.95B | - | 61 | Compare |
More PTGX Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry